Sujal Shah
CIK 1588861 · Chief Executive Officer · last filed 2026-06-11
Sujal Shah is a Chief Executive Officer who has filed 35 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for TVRD, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$2.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
35
-$2.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVRD | Director | — | $2.64 | — | $0 | 2 | 2026-06-11 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Chief Executive Officer | 0 | $32.48 | $0 | -$2.62M | 30 | 2024-03-22 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | TVRD | Grant (A) | — | $0 | EDGAR |
| 2025-04-21 | TVRD | Grant (A) | — | $0 | EDGAR |
| 2025-04-17 | — | Grant (A) | — | $0 | |
| 2024-03-22 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Disp (D) | −406,670 | $0 | EDGAR |
| 2024-03-15 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Exer (M) | +139,119 | $656.0K | EDGAR |
| 2024-01-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | +96,250 | $0 | EDGAR |
| 2023-12-11 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$972.8K | EDGAR |
| 2023-11-14 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$706.3K | EDGAR |
| 2023-10-10 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$597.0K | EDGAR |
| 2023-01-27 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |